Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s traded shares stood at 1.06 million during the latest session, with the company’s beta value hitting 0.76. At the last check today, the stock’s price was $0.77, to imply an increase of 17.31% or $0.11 in intraday trading. The ASBP share’s 52-week high remains $15.80, putting it -1951.95% down since that peak but still an impressive 32.47% since price per share fell to its 52-week low of $0.52. The company has a valuation of $35.62M, with an average of 1.79 million shares in intraday trading volume over the past 10 days and average of 565.91K shares over the past 3 months.
Aspire Biopharma Holdings Inc (NASDAQ:ASBP) trade information
After registering a 17.31% upside in the latest session, Aspire Biopharma Holdings Inc (ASBP) has traded red over the past five days. The 5-day price performance for the stock is 33.47%, and -91.62% over 30 days. With these gigs, the year-to-date price performance is -93.27%. Short interest in Aspire Biopharma Holdings Inc (NASDAQ:ASBP) saw shorts transact 47452.0 shares and set a 0.09 days time to cover.
ASBP Dividends
Aspire Biopharma Holdings Inc has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Aspire Biopharma Holdings Inc (NASDAQ:ASBP)’s Major holders
Aspire Biopharma Holdings Inc insiders hold 26.06% of total outstanding shares, with institutional holders owning 1.03% of the shares at 1.39% float percentage. In total, 1.03% institutions holds shares in the company.
We also have Fidelity Nasdaq Composite Index Fund and Robinson Alternative Yield Pre-Merger SPAC ETF as the top two Mutual Funds with the largest holdings of the Aspire Biopharma Holdings Inc (ASBP) shares. Going by data provided on Dec 31, 2024 , Fidelity Nasdaq Composite Index Fund holds roughly 5.29 shares. This is just over 0.07% of the total shares, with a market valuation of $4230.0. Data from the same date shows that the other fund manager holds a little less at 3.07, or 0.04% of the shares, all valued at about 2458.0.
